IFNG and neoplasm: Nakanishi et al. noted that daily oral administration of celecoxib in tumor-bearing mice (colon cancer) resulted in enhanced secretion of IFN-γ by T cells and natural killer cells and altered the immune inhibitory effect in the tumor microenvironment, which in turn induced differentiation of macrophages into M1 macrophages and inhibited tumor growth [47].